Overview

Comparison of Antibiotics for Pseudomonas in Early CF

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized clinical trial comparing the effects of these 2 modes of antibiotic treatment on BALF inflammation in young, P. aeruginosa-positive CF patients.
Phase:
Phase 1
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborators:
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Therapeutics
Treatments:
Anti-Bacterial Agents
Ceftazidime
Tobramycin